GSK plc Sponsored ADR
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.72 USD
7.53 B USD
43.05 B USD
2.02 B
About GSK plc
Sector
Industry
CEO
Luke Miels
Website
Headquarters
London
IPO date
May 22, 1972
Identifiers
3
ISIN US37733W2044
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
83GI
GlaxoSmithKline Capital Plc 5.25% 10-APR-2042Yield to maturity
5.66%
Maturity date
Apr 10, 2042
17RI
GlaxoSmithKline Capital Plc 4.25% 18-DEC-2045Yield to maturity
5.61%
Maturity date
Dec 18, 2045
71ZC
GlaxoSmithKline Capital Plc 6.375% 09-MAR-2039Yield to maturity
5.50%
Maturity date
Mar 9, 2039
GSK3981911
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043Yield to maturity
5.29%
Maturity date
Mar 18, 2043
XS217060907
GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035Yield to maturity
5.08%
Maturity date
May 12, 2035
GSK.GJ
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038Yield to maturity
4.97%
Maturity date
May 15, 2038
GSK6023693
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035Yield to maturity
4.70%
Maturity date
Apr 15, 2035
72WI
GlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034Yield to maturity
4.67%
Maturity date
Apr 15, 2034
AG99
GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033Yield to maturity
4.61%
Maturity date
Dec 19, 2033
GSK6023695
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030Yield to maturity
4.04%
Maturity date
Apr 15, 2030
US377373AH8
GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029Yield to maturity
3.99%
Maturity date
Jun 1, 2029
See all GSK bonds
